This drug maker could see shares double on new data, BTIG says

BioAge Labs could more than double amid the release of more data on its anti-inflammation and weight loss drugs over the next year, according to BTIG. The investment firm initiated coverage of the biopharmaceutical name with a buy rating. It also set… [1409 chars]